{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-012969","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2024-09-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.025740+00:00","generated_at":"2026-05-31T02:01:34.650321+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ReShape Lifesciences announces 1-for-58 reverse stock split effective Sept 23, 2024","bullets":["Reverse split ratio 1:58, effective at trading open on September 23, 2024.","Fractional shares resulting from the split will be rounded up to the nearest whole share.","Proportional adjustments made to outstanding warrants, stock options, and convertible preferred.","Authorized shares unchanged; split approved by stockholders on February 23, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-012969","json":"https://secwatch.observer/filing/0001558370-24-012969.json","markdown":"https://secwatch.observer/filing/0001558370-24-012969.md","text":"https://secwatch.observer/filing/0001558370-24-012969.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000155837024012969/0001558370-24-012969-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000155837024012969/rsls-20240918x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T02:01:34.650321+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}